Cara Therapeutics, Inc. ( CARA) - Stock Earnings
Stock symbol CARA is outdated, potentially delisted? Maybe it is available on other exchange?
CARA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -30.7 million USD | 2.1 million USD |
| 2024Q2 | -20.0 million USD | 991000 USD |
| 2024Q3 | -12.5 million USD | 2.6 million USD |
CARA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -88.2 million USD | 23.0 million USD |
| 2022 | -83.4 million USD | 41.9 million USD |
| 2023 | -118.5 million USD | 21.0 million USD |
CARA
Price: $5.32
52 week price:
Earnings Per Share: -15.53 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 393100
Ebitda: -12.8 millionMarket Capitalization: 22.6 million